FDA Announces Changes To ED Drug Labels

Law360, New York (October 19, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said Thursday that it has approved labeling changes for three popular erectile dysfunction drugs to better warn consumers about a possible risk of sudden hearing loss.

Pfizer Inc.'s Viagra, Eli Lilly & Co.'s Cialis, and Levitra, marketed jointly by Schering-Plough Corp. and GlaxoSmithKline Inc., already include warning labels for possible auditory side effects. The new labels will display a more prominent and specific warning about sudden hearing loss, and include new information for patients about what they should do if...
To view the full article, register now.